The recent developments in immuno-oncology have opened an unprecedented avenue for
the emergence of vaccine strategies. Therapeutic DNA cancer vaccines are now considered …

Breast cancer is currently the most common form of cancer and the second‐leading cause of
death from cancer in women. Though considerable progress has been made in the …

Abstract The Feline Leukemia Virus Subgroup C Receptor 1a (FLVCR1a) is a
transmembrane heme exporter essential for embryonic vascular development. However, the …

Despite the potential of the enhanced permeability and retention (EPR) effect in tumor
passive targeting, many nanotherapeutics have failed to produce meaningful clinical …

It was established through in vivo T1 measurements at low magnetic fields that tumour cells
display proton T1 values that are markedly longer than those shown by healthy tissue …

This study identifies physiological tumor habitats from quantitative magnetic resonance
imaging (MRI) data and evaluates their alterations in response to therapy. Two models of …

Optoacoustic imaging emerged in early 1990s as a new biomedical imaging technology that
generates images by illuminating tissues with short laser pulses and detecting resulting …

Rationale: Tumor vascular normalization (TVN) is emerging to enhance the efficacy of
anticancer treatment in many cancers including glioblastoma (GBM). However, a common …

Cancer cells reprogram their metabolism to maintain viability via genetic mutations and
epigenetic alterations, expressing overall dynamic heterogeneity. The complex relaxation …

Antiangiogenic therapy used in treatment of metastatic colorectal cancer (mCRC) inevitably
succumbs to treatment resistance. Upregulation of MET may play an essential role to …